Northeast Investment Management Novartis Ag Transaction History

Northeast Investment Management

  • $2.18 Billion
  • Q3 2024

A detailed history of Northeast Investment Management transactions in Novartis Ag stock. As of the latest transaction made, Northeast Investment Management holds 32,098 shares of NVS stock, worth $3.16 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
32,098
Previous 32,153 0.17%
Holding current value
$3.16 Million
Previous $3.42 Million 7.83%
% of portfolio
0.17%
Previous 0.16%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024
SELL
$106.13 - $120.89 $5,837 - $6,648
-55 Reduced 0.17%
32,098 $3.69 Million
Q2 2024

Jul 26, 2024
BUY
$92.57 - $107.37 $576,063 - $668,163
6,223 Added 24.0%
32,153 $3.42 Million
Q1 2024

May 01, 2024
SELL
$95.27 - $108.47 $40,203 - $45,774
-422 Reduced 1.6%
25,930 $2.51 Million
Q4 2023

Feb 09, 2024
SELL
$92.27 - $101.54 $62,282 - $68,539
-675 Reduced 2.5%
26,352 $2.66 Million
Q3 2023

Nov 08, 2023
SELL
$94.73 - $105.13 $146,547 - $162,636
-1,547 Reduced 5.41%
27,027 $2.75 Million
Q2 2023

Jul 28, 2023
BUY
$92.52 - $104.91 $4,996 - $5,665
54 Added 0.19%
28,574 $2.88 Million
Q1 2023

Apr 28, 2023
SELL
$80.03 - $92.81 $5,121 - $5,939
-64 Reduced 0.22%
28,520 $2.62 Million
Q4 2022

Jan 27, 2023
SELL
$75.55 - $92.52 $67,315 - $82,435
-891 Reduced 3.02%
28,584 $2.59 Million
Q3 2022

Oct 28, 2022
SELL
$74.61 - $87.26 $69,387 - $81,151
-930 Reduced 3.06%
29,475 $2.24 Million
Q2 2022

Aug 05, 2022
SELL
$80.52 - $93.75 $31,402 - $36,562
-390 Reduced 1.27%
30,405 $2.57 Million
Q1 2022

May 04, 2022
SELL
$80.11 - $90.62 $24,914 - $28,182
-311 Reduced 1.0%
30,795 $2.7 Million
Q4 2021

Feb 07, 2022
SELL
$79.7 - $88.13 $550,408 - $608,625
-6,906 Reduced 18.17%
31,106 $2.72 Million
Q3 2021

Nov 08, 2021
SELL
$81.78 - $95.14 $194,227 - $225,957
-2,375 Reduced 5.88%
38,012 $3.11 Million
Q2 2021

Aug 05, 2021
SELL
$85.24 - $94.15 $168,349 - $185,946
-1,975 Reduced 4.66%
40,387 $3.69 Million
Q1 2021

May 11, 2021
SELL
$83.5 - $98.47 $262,357 - $309,392
-3,142 Reduced 6.9%
42,362 $3.62 Million
Q4 2020

Feb 10, 2021
SELL
$78.07 - $94.43 $235,224 - $284,517
-3,013 Reduced 6.21%
45,504 $4.3 Million
Q3 2020

Nov 13, 2020
SELL
$82.14 - $91.0 $2,299 - $2,548
-28 Reduced 0.06%
48,517 $4.22 Million
Q2 2020

Aug 11, 2020
BUY
$80.93 - $91.1 $207,585 - $233,671
2,565 Added 5.58%
48,545 $4.24 Million
Q1 2020

May 13, 2020
SELL
$70.67 - $99.01 $83,390 - $116,831
-1,180 Reduced 2.5%
45,980 $3.79 Million
Q4 2019

Feb 12, 2020
SELL
$84.35 - $95.37 $34,752 - $39,292
-412 Reduced 0.87%
47,160 $4.47 Million
Q3 2019

Nov 13, 2019
SELL
$85.54 - $94.26 $9,323 - $10,274
-109 Reduced 0.23%
47,572 $4.13 Million
Q2 2019

Aug 12, 2019
BUY
$75.4 - $92.8 $75 - $92
1 Added 0.0%
47,681 $4.35 Million
Q1 2019

May 14, 2019
SELL
$75.32 - $86.15 $677 - $775
-9 Reduced 0.02%
47,680 $4.58 Million
Q4 2018

Feb 13, 2019
SELL
$73.66 - $82.02 $120,065 - $133,692
-1,630 Reduced 3.31%
47,689 $4.09 Million
Q3 2018

Nov 13, 2018
SELL
$66.94 - $77.43 $665,249 - $769,499
-9,938 Reduced 16.77%
49,319 $4.25 Million
Q2 2018

Aug 13, 2018
SELL
$64.91 - $73.36 $300,987 - $340,170
-4,637 Reduced 7.26%
59,257 $4.48 Million
Q1 2018

May 15, 2018
BUY
$70.39 - $84.15 $34,279 - $40,981
487 Added 0.77%
63,894 $5.17 Million
Q4 2017

Jan 29, 2018
SELL
$72.33 - $77.64 $6,871 - $7,375
-95 Reduced 0.15%
63,407 $5.32 Million
Q3 2017

Nov 13, 2017
BUY
$74.14 - $77.27 $4.71 Million - $4.91 Million
63,502
63,502 $5.45 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Northeast Investment Management Portfolio

Follow Northeast Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Investment Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email